{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:37:53Z","timestamp":1777012673778,"version":"3.51.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>Patients with influenza or Coronavirus disease 2019 (COVID-19) are at risk of developing invasive pulmonary aspergillosis (IPA). Whether the clinical profiles and outcomes differ between influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) remains unclear, hindering efforts to optimize management. This study aimed to compare the demographic, clinical, laboratory characteristics, and outcomes of patients with IPA following influenza A\/B versus COVID-19 during the same period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a single-center retrospective cohort study in China from December 1, 2022, to September 1, 2024. The study included 45 patients with IAPA and 82 patients with CAPA. We compared demographics, clinical features, management, and mortality between the IAPA and CAPA patients. Group comparisons utilized Student\u2019s\n                      <jats:italic>t<\/jats:italic>\n                      -test or the Mann-Whitney\n                      <jats:italic>U<\/jats:italic>\n                      test for continuous variables, the Chi-square or Fisher\u2019s exact test for categorical variables, and Kaplan-Meier survival curves, and time-dependent Cox proportional hazards model for survival data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to IAPA patients, CAPA patients had significantly lower lymphocytes, especially in CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, and B cells (all\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Corticosteroid use was more frequent among CAPA patients than IAPA patients. The median time from viral diagnosis to IPA detection was longer in CAPA patients than in IAPA patients. Respiratory co-infections (bacterial) were more common in the CAPA group (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.030). After adjusting for confounders, the risk of death within the first 14 days following IPA diagnosis was 4.92 times higher in the CAPA group than in the IAPA group (HR = 4.92, 95% CI: 1.35\u201318.01,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.016).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CAPA was independently associated with an approximately five-fold increase in the risk of death within the first 14 days following IPA diagnosis. This early hazard, together with the higher frequency of corticosteroid use, respiratory co-infections (bacterial), and severe lymphopenia, underscores a critical window for early therapeutic intervention in patients with CAPA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1790007","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:42:21Z","timestamp":1777009341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative clinical features and outcomes of invasive pulmonary aspergillosis following influenza versus COVID-19: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Renwen","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project.","volume":"9","author":"Paget","year":"2019","journal-title":"J Glob Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19.","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41435-021-00140-w","article-title":"Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome\u2014with a preliminary reference to SARS-CoV-2 pneumonia.","volume":"22","author":"Land","year":"2021","journal-title":"Genes Immun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/v15061339","article-title":"Roles and mechanisms of NLRP3 in influenza viral infection.","volume":"15","author":"Niu","year":"2023","journal-title":"Viruses."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0023425","DOI":"10.1128\/iai.00234-25","article-title":"Loss of pulmonary tissue protection and neutrophil microbicidal defects promote severe Aspergillus fumigatus infection during influenza A virus infection.","volume":"93","author":"Wang","year":"2025","journal-title":"Infect Immun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12941-025-00805-8","article-title":"SARS-CoV-2 co-infection in patients with invasive pulmonary Aspergillosis: clinical characteristics and prognosis.","volume":"24","author":"Xie","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/cid\/ciaa010","article-title":"Influenza-associated pulmonary Aspergillosis: a local or global lethal combination?","volume":"71","author":"Rijnders","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/ciz391","article-title":"Influenza co-infection: Be(a)ware of Invasive Aspergillosis.","volume":"70","author":"Verweij","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review.","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41598-023-29364-8","article-title":"Risk of mortality in COVID-19 patients: a meta- and network analysis.","volume":"13","author":"Kowsar","year":"2023","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jmii.2022.09.006","article-title":"Coronavirus disease 2019 (COVID-19) associated bacterial co-infection: incidence, diagnosis and treatment.","volume":"55","author":"Wu","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12703","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients.","volume":"11","author":"Shafran","year":"2021","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"711616","DOI":"10.3389\/fpubh.2021.711616","article-title":"COVID-19: pulmonary and extra pulmonary manifestations.","volume":"9","author":"Elrobaa","year":"2021","journal-title":"Front Public Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","article-title":"State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.","volume":"49","author":"Chong","year":"2021","journal-title":"Infection"},{"key":"B17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10096-024-04772-4","article-title":"Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.","volume":"43","author":"Zhao","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-025-05830-9","article-title":"Longitudinal mycological profiling of influenza-associated and COVID-19-associated pulmonary aspergillosis.","volume":"30","author":"Delanote","year":"2026","journal-title":"Crit Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.2147\/IDR.S542063","article-title":"Clinical characteristics, prognosis, and risk factors for mortality in influenza-associated pulmonary Aspergillosis and COVID-19-associated pulmonary Aspergillosis: a multicenter retrospective study.","volume":"18","author":"Jiang","year":"2025","journal-title":"Infect Drug Resist."},{"key":"B23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/jof7050388","article-title":"Influenza- and COVID-19-associated pulmonary Aspergillosis: Are the pictures different?","volume":"7","author":"Reizine","year":"2021","journal-title":"J Fungi."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease From the European organization for research and treatment of cancer and the mycoses study group education and research consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ ISHAM consensus criteria for research and clinical guidance.","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s40001-023-01305-1","article-title":"Respiratory co-infections in COVID-19-positive patients.","volume":"28","author":"M Abd El-Halim","year":"2023","journal-title":"Eur J Med Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"653399","DOI":"10.3389\/fmicb.2021.653399","article-title":"Respiratory Co-infections: modulators of SARS-CoV-2 Patients\u2019 clinical sub-phenotype.","volume":"12","author":"Mehta","year":"2021","journal-title":"Front Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3949\/ccjm.87a.ccc015","article-title":"Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19.","volume":"87","author":"Wu","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/emp2.12128","article-title":"Viral and atypical respiratory co-infections in COVID-19: a systematic review and meta-analysis.","volume":"1","author":"Davis","year":"2020","journal-title":"J Am Coll Emerg Physicians Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"108507","DOI":"10.1016\/j.ijid.2026.108507","article-title":"Characteristics of respiratory co-infections in influenza-like illness during the post-COVID-19 Era.","volume":"166","author":"Yonghao","year":"2026","journal-title":"Int J Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"110136","DOI":"10.1016\/j.isci.2024.110136","article-title":"Ten-year retrospective data analysis reveals frequent respiratory co-infections in hospitalized patients in Augsburg.","volume":"27","author":"Krammer","year":"2024","journal-title":"iScience."},{"key":"B33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccc.2023.12.001","article-title":"Diagnosis and epidemiology of acute respiratory failure.","volume":"40","author":"Chen","year":"2024","journal-title":"Crit Care Clin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/infdis\/jiab163","article-title":"Navigating the uncertainties of COVID-19-associated Aspergillosis: a comparison with influenza-associated Aspergillosis.","volume":"224","author":"Lamoth","year":"2021","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of respiratory viral and fungal coinfections.","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12879-023-08226-8","article-title":"Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country.","volume":"23","author":"Negm","year":"2023","journal-title":"BMC Infect Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e13693","DOI":"10.1111\/myc.13693","article-title":"Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary Aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.","volume":"67","author":"Hern\u00e1ndez-Silva","year":"2024","journal-title":"Mycoses."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1164\/rccm.202401-0145OC","article-title":"Profiling bacteria in the lungs of patients with severe influenza versus COVID-19 with or without Aspergillosis.","volume":"210","author":"Feys","year":"2024","journal-title":"Am J Respir Crit Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7507\/1671-6205.202306031","article-title":"Clinical characteristics of COVID-19-associated pulmonary Aspergillosis.","volume":"22","author":"Li","year":"2023","journal-title":"Chin J Respir Crit Care Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1186\/s12879-025-11452-x","article-title":"Influenza-related invasive pulmonary aspergillosis in an infectious disease ward at a pulmonary referral center in Iran.","volume":"25","author":"Valikhani","year":"2025","journal-title":"BMC Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.21037\/jtd-2025-1198","article-title":"Risk and prognostic patterns of viral-associated invasive pulmonary Aspergillosis: impact of corticosteroid and antibiotic exposure in non-neutropenic hosts.","volume":"17","author":"Liu","year":"2025","journal-title":"J Thorac Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/jac\/dkaf261","article-title":"Classifying patients with invasive fungal disease: towards a unified case definition?","volume":"80","author":"Erg\u00fcn","year":"2025","journal-title":"J Antimicrob Chemother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1790007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:42:23Z","timestamp":1777009343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1790007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":42,"alternative-id":["10.3389\/fmed.2026.1790007"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1790007","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1790007"}}